Articles From: Adallom and Check Point Announce Partnership for SaaS Document Protection to ADDING MULTIMEDIA FDA Expands Indication for REVLIMID® (Lenalidomide) in Combination with Dexamethasone to Include Patients Newly Diagnosed with Multiple Myeloma


2015/2/24
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1175794&ProfileId=051205&sourceType=1 PALO ALTO, CA --
Sign-up for Adallom and Check Point Announce Partnership for SaaS Document Protection investment picks
2015/1/27
LAS VEGAS, NV --
Sign-up for Adallom Extends FireEye Threat Analytics Platform With Cloud Visibility investment picks
2015/2/23
OWEGO, N.Y. , Feb.
Sign-up for Adam Weitsman of Upstate Shredding Proposes to Acquire Metalico, Inc. for $0.78 Per Share investment picks
2014/12/2
EMERYVILLE, Calif., Dec.
Sign-up for Adamas Pharmaceuticals Issued Six Additional U.S. Patents investment picks
2015/1/11
EMERYVILLE, Calif., Jan.
Sign-up for Adamas Pharmaceuticals Provides Review of 2014 and Previews Upcoming Business Drivers investment picks
2015/1/8
EMERYVILLE, Calif., Jan.
Sign-up for Adamas Pharmaceuticals Receives $30 Million Milestone Payment From Actavis investment picks
2015/2/9
EMERYVILLE, Calif., Feb.
Sign-up for Adamas Pharmaceuticals' Phase 2/3 Clinical Study Published in Movement Disorders investment picks
2014/12/24
Shares of Adamas Pharmaceuticals (ADMS) shot up 16% in premarket trade Wednesday, after the company and development partner Actavis (ACT) said the new drug application for Namzaric for the treatment of Alzheimer's-type dementia was approved by the U.S. Food and Drug Administration.
Sign-up for Adamas' stock soars after dementia treatment approval investment picks
2015/1/9
SAN DIEGO, Jan.
Sign-up for Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock investment picks
2015/1/8
SAN DIEGO, Jan.
Sign-up for Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock investment picks
2014/12/2
SAN DIEGO, Dec.
Sign-up for Adamis Pharmaceuticals to Present at Two Upcoming Conferences investment picks
2015/1/21
BALTIMORE , Jan.
Sign-up for Adams Express Fund Announces Management Changes investment picks
2015/1/8
BALTIMORE , Jan.
Sign-up for Adams Express Fund Declares Dividend investment picks
2014/12/3
SAN JOSE, Calif.
Sign-up for Adams NetWorks Selects Sphere 3D's Virtualization Solutions for Telecom Service Providers investment picks
2015/2/24
HOUSTON , Feb.
Sign-up for Adams Resources Announces First Quarter 2015 Dividend investment picks
2015/1/29
New Partners to Build Out NetSuite-Focused Businesses with NetSuite Cloud SAN MATEO, Calif.
Sign-up for Adaptive Road, BrainSell And FayeBSG Join NetSuite Solution Provider Program investment picks
2015/1/20
ATLANTA , Jan.
Sign-up for AdCare Health Systems Leases 10 Facilities in Arkansas investment picks
2015/2/3
ATLANTA , Feb.
Sign-up for AdCare Health Systems Leases Two Facilities in Georgia investment picks
2015/2/19
Company Reaffirms Expectations to Have Majority of Remaining Facilities Leased or Subleased by the End of Q1 2015, Subject to Required Approvals ATLANTA , Feb.
Sign-up for AdCare Health Systems Leases Two Facilities in Georgia; Now has leased 28 of 37 Facilities investment picks
2014/12/18
Long-term, HUD-Backed Financing Secured for Autumn Breeze Facility ATLANTA , Dec.
Sign-up for AdCare Health Systems Refinances Georgia Property, Reduces Interest Expense investment picks
2015/2/10
MAHWAH, N.J., Feb.
Sign-up for ADCs Move Beyond Load Balancing Into Critical Security Role for Enterprises investment picks
2015/2/23
By William Watts, MarketWatch Icahn, Paulson among those bruised by crude's drop NEW YORK (MarketWatch) -- Bill Gross is among a number of investors licking their wounds from the steep plunge in oil prices.
Sign-up for Add Bill Gross to list of plunging oil's victims investment picks
2014/12/17
Please add the Consolidated Condensed Statement of Cash Flows at the end of the release due to inadvertent omission by Business Wire.
Sign-up for ADDING and REPLACING Apogee Reports Significant Fiscal 2015 Q3 Sales, Earnings Growth investment picks
2015/2/19
Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has expanded the existing indication for REVLIMID ® (lenalidomide) in combination with dexamethasone to include patients newly diagnosed with multiple myeloma (NDMM). REVLIMID plus dexamethasone was previously approved in June 2006 for use in multiple myeloma patients who have received at least one prior therapy.
Sign-up for ADDING MULTIMEDIA FDA Expands Indication for REVLIMID® (Lenalidomide) in Combination with Dexamethasone to Include Patients Newly Diagnosed with Multiple Myeloma investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Adallom and Check Point Announce Partnership for SaaS Document Protection to ADDING MULTIMEDIA FDA Expands Indication for REVLIMID® (Lenalidomide) in Combination with Dexamethasone to Include Patients Newly Diagnosed with Multiple Myeloma
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent